Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Grant is an opportunity for funding provided to support a range of studies that focus on improving the practical application of evidence-based healthcare approaches. The intention of this grant is to promote studies that strive to identify, develop, and test strategies to overcome challenges in introducing, adapting, integrating, expanding, and maintaining the use of proven interventions, practices, programs, tools, treatments, guidelines, and policies.

This funding opportunity also places a focus on equitable dissemination, meaning it encourages studies that aim to further the implementation of these evidence-based interventions specifically in underrepresented communities.

On the other hand, understanding situations that necessitate the decrease or complete cessation of practices that have proven ineffective, are not scientifically confirmed, provide little value or can potentially cause harm is also valued by this grant. In essence, it also aims to avoid wastage of resources on ineffective methods.

The grant supports studies that aim to advance methodologies and measures related to dissemination and implementation research as well. This means it encourages advances in the methods used to spread and put to use evidence-based healthcare approaches.

In order to be eligible for consideration, all applications for this funding opportunity need to be aligned with the mission statement of one or more of the Institutes or Centers mentioned in the grant description.